Added to YB: 2025-11-10
Pitch date: 2025-11-04
EVOK [neutral]
Evoke Pharma, Inc.
+2.15%
current return
Author Info
BiotechBonanza shares takes on biotech with a heavy focus on special situations. Sign up for the newsletter.
Company Info
Evoke Pharma, Inc. operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases.
Market Cap
$22.3M
Pitch Price
$10.72
Price Target
N/A
Dividend
N/A
EV/EBITDA
-3.12
P/E
-5.69
EV/Sales
1.10
Sector
Pharmaceuticals
Category
special_situation
3 quick merger arb ideas at >10% yield - Evoke Pharma, Inc.
EVOK (tender offer): Fresh tender offer at $11 cash, trading ~$10.72 (17% annualized yield). Closing expected Dec 30, 56 days. 10% votes secured (likely Nantahala). High warrant count may pressure stock. Private buyer with resolved negative history, no financing condition. Large downside if deal breaks.
Read full article (1 min)